Merlin/NF2-Lin28B-let-7 Is a Tumor-Suppressive Pathway that Is Cell-Density Dependent and Hippo Independent  by Hikasa, Hiroki et al.
ArticleMerlin/NF2-Lin28B-let-7 Is a Tumor-Suppressive
Pathway that Is Cell-Density Dependent and Hippo
IndependentGraphical AbstractHighlightsd Lin28B, which inhibits let-7 microRNA, is a key downstream
target of Merlin/NF2
d At low cell density, phosphorylated Merlin/NF2 does not bind
to Lin28B
d Dephosphorylated Merlin/NF2 sequesters Lin28B, inhibiting
growth
d Merlin/NF2 drives cell-density-dependent and Hippo-
independent tumor suppressionHikasa et al., 2016, Cell Reports 14, 2950–2961
March 29, 2016 ª2016 The Authors
http://dx.doi.org/10.1016/j.celrep.2016.02.075Authors
Hiroki Hikasa, Yoshitaka Sekido,
Akira Suzuki
Correspondence
suzuki@bioreg.kyushu-u.ac.jp
In Brief
Hikasa et al. reveal an essential growth-
inhibitory mechanism, by which Merlin/
NF2 suppresses Lin28B function and
promotes let-7 biogenesis in a YAP1/
TAZ-independent manner. Contact
inhibition triggers Merlin/NF2
dephosphorylation, which inhibits
nucleolar/nuclear localization of Lin28B
and induces pri-let7 maturation, leading
to cell growth inhibition. They suggest
that Merlin/NF2 thereby drives a cell-
density-dependent tumor-suppressive
pathway.
Cell Reports
ArticleMerlin/NF2-Lin28B-let-7 Is a Tumor-Suppressive
Pathway that Is Cell-Density Dependent
and Hippo Independent
Hiroki Hikasa,1 Yoshitaka Sekido,2 and Akira Suzuki1,*
1Division of Cancer Genetics, Medical Institute of Bioregulation, Graduate School of Medical Sciences, Kyushu University,
Fukuoka 812-8582, Japan
2Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan
*Correspondence: suzuki@bioreg.kyushu-u.ac.jp
http://dx.doi.org/10.1016/j.celrep.2016.02.075
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).SUMMARY
Contact inhibition of proliferation is critical for tissue
organization, and its dysregulation contributes to
tumorigenesis. Merlin/NF2 is a tumor suppressor
that governs contact inhibition. Although Merlin/
NF2 inhibits YAP1 and TAZ, which are paralogous
Hippo pathway transcriptional co-activators and on-
coproteins, it is not fully understood howMerlin/NF2-
mediated signal transduction triggered by cell-cell
contact exerts tumor suppression. Here, we identify
Lin28B, an inhibitor of let-7 microRNAs (miRNAs),
as an important downstream target of Merlin/NF2.
Functional studies revealed that, at low cell density,
Merlin/NF2 is phosphorylated and does not bind to
Lin28B, allowing Lin28B to enter the nucleus, bind
to pri-let-7 miRNAs, and inhibit their maturation in
a YAP1/TAZ-independent manner. This inhibition of
pri-let-7maturation then promotes cell growth. How-
ever, cell-cell contact triggers Merlin/NF2 dephos-
phorylation, which sequesters Lin28B in the cyto-
plasm and permits pri-let-7 maturation. Our results
reveal that Merlin/NF2-mediated signaling drives
a tumor-suppressive pathway that is cell-density
dependent and Hippo independent.INTRODUCTION
Intercellular contact leads to inhibition of cell proliferation, a
process called contact inhibition. Contact inhibition is essential
for the maintenance of tissue homeostasis, and its disruption is
characteristic of cancer (Hanahan and Weinberg, 2011). Merlin,
also known as neurofibromatosis type 2 (NF2), is a major
effector of contact inhibition and also a tumor suppressor
gene (Curto et al., 2007; Morrison et al., 2001; Okada et al.,
2005; Yi et al., 2011). The presence of inactivated Merlin/NF2
in a variety of cancers in both mice and humans is evidence
of Merlin/NF2’s potent tumor-suppressive activity (Li et al.,
2012; Sekido, 2013).2950 Cell Reports 14, 2950–2961, March 29, 2016 ª2016 The AuthorMerlin/NF2 is a FERM-domain-containing protein and serves
as a linker between transmembrane proteins and a cell’s actin
cytoskeleton. Merlin/NF2 inhibits mitogenic signal transduc-
tion, and several lines of evidence suggest that this growth-
inhibitory role is associated with receptor-dependent pathways
such as EGFR-RAS signaling (Benhamouche et al., 2010;
Curto et al., 2007), Rac-PAK signaling (Kissil et al., 2003;
Okada et al., 2005; Xiao et al., 2002), and HA-CD44 signaling
(Bai et al., 2007; Morrison et al., 2001). Furthermore, there is
genetic evidence in mice and flies that Merlin/NF2 activates
the tumor-suppressive Hippo pathway that is important for
contact inhibition. This Hippo pathway activation leads to inhi-
bition of the paralogous transcriptional coactivators YAP1 and
TAZ, which are key regulators of cell proliferation (Hong and
Guan, 2012; Pellock et al., 2007; Yu et al., 2010; Zhang
et al., 2010). In addition, recent studies have demonstrated
that nuclear Merlin/NF2 inhibits the CRLDCAF1-mediated
proteolysis pathway critical for cell growth (Li et al., 2010,
2014). However, although it is clear that Merlin/NF2 function-
ally interacts with a variety of signal-transduction pathways
controlling cell proliferation and survival, it remains to be
elucidated which pathway contributes to Merlin/NF2’s tumor-
suppressive activity during contact-mediated inhibition of cell
proliferation.
There is emerging evidence that the RNA-binding protein
Lin28 is involved in cell growth and reprogramming, as well as
in tissue homeostasis and cancer development (Rehfeld et al.,
2015; Thornton and Gregory, 2012; Zhou et al., 2013). When
Lin28 is overexpressed in mice, it enhances the metabolism of
glucose and other bioenergetic molecules, leading to delayed
onset of puberty, resistance to the development of obesity and
diabetes, and enhanced tissue repair (Shyh-Chang et al., 2013;
Zhu et al., 2010, 2011). In addition, mice with tissue-specific
overexpression of Lin28 in neural crest, liver or small intestine
develop tumors (Madison et al., 2013; Molenaar et al., 2012;
Nguyen et al., 2014). Mechanistically, Lin28 regulates the trans-
lation of various mRNAs (Cho et al., 2012; Graf et al., 2013; Mayr
and Heinemann, 2013; Shyh-Chang et al., 2013; Wilbert et al.,
2012) and specifically suppresses the biogenesis of the let-7
microRNA (miRNA) family (Roush and Slack, 2008; Viswanathan
and Daley, 2010). Let-7 miRNAs act as tumor suppressors by
silencing the expression of critical oncogenes such as Myc,s
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Figure 1. Merlin/NF2’s FERM and a-Helix Domains Mediate Interaction with Lin28B’s Cold Shock Domain
(A) Immunoblot (IB) to detect the indicated proteins in lysates of HEK293T cells that expressedmyc-tagged Lin28B plus flag-tagged Merlin/NF2 (flagMer) or flag-
tagged MST1 and were subjected to immunoprecipitation (IP) with anti-flag Ab (aflag). GFP, transfection control. For all IB, results are representative of three
experiments.
(B) IB to detect the indicated endogenous proteins in lysates of H1299 cells subjected to IP with anti-Lin28B Ab or control IgG.
(C) IB of H1299 cells that were infected with lentivirus expressing the indicated flagMer constructs and immunoprecipitated with anti-flag Ab to detect the binding
of endogenous Lin28B to flagMer constructs. Mer WT, wild-type Merlin/NF2 protein showing the FERM (F for 4.1 protein, E for ezrin, R for radixin and M for
moesin), a-helix and C-terminal domains. MerDF, Merlin/NF2 protein missing 91 amino acids of the FERM domain; MerDH,Merlin/NF2 proteinmissing the entire
a-helix domain; Mer DC, Merlin/NF2 protein missing the entire C-terminal domain.
(D) IB to detect the indicated proteins in HEK293T cells that were co-transfected with the indicated mycLin28B constructs plus GFP or flagMer, and immuno-
precipitated with anti-flag Ab. Lin28B WT, wild-type Lin28B protein showing the CSD (cold shock domain), L (linker domain), Zinc finger (Zinc F), and C-terminal
domains. Lin28B DC, Lin28B protein missing the entire CSD domain; Lin28B DL, Lin28B protein missing the entire linker domain; Lin28B DZ, Lin28B protein
missing the entire zinc-finger domain plus 77 amino acids of the C-terminal domain.HMGA2, IMP1, and RAS (Johnson et al., 2005; Kumar et al.,
2007; Lee and Dutta, 2007; Nishino et al., 2008). Lin28 inhibits
the synthesis of the mature form of let-7 (mlet-7) at two distinct
subcellular levels. In the nucleus, Lin28 associates with primary
let-7 (pri-let-7) to block Drosha-mediated processing of this
molecule into precursor let-7 (pre-let-7) (Van Wynsberghe
et al., 2011; Viswanathan et al., 2008). In the cytoplasm, Lin28
binds to pre-let-7, inducing its TUT4/7-mediated oligouridylation
and rapid decay (Hagan et al., 2009; Heo et al., 2008, 2009; Lehr-
bach et al., 2009).
There are two isoforms of mammalian Lin28: the closely
related paralogs Lin28A and Lin28B. Several types of primary
human tumors express either Lin28A or Lin28B, and both iso-
forms function as oncoproteins when expressed ectopically.
Lin28A is thought to act on pri-let-7 miRNAs in the nucleus and
on pre-let-7mRNAs in the cytoplasm (Kim et al., 2014), whereas
Lin28B preferentially acts on nuclear pri-let-7 miRNAs (Piskou-
nova et al., 2011). However, the pathways regulating Lin28A/B
localization and activity in response to intercellular signaling
are still unknown.
In this report, we demonstrate that (1) Lin28B interacts with
Merlin/NF2, (2) Merlin/NF2 is a key regulator of Lin28B localiza-
tion and mlet-7 biogenesis in response to cell-cell contact, and
(3) Lin28-let-7 interaction makes a major contribution to Merlin/
NF2’s growth inhibitory activity. Our results show that the
Merlin/NF2-Lin28-let-7 axis is a cell-density-dependent tumor-
suppressive pathway.CellRESULTS
Merlin/NF2 Associates with Lin28B
To identify signaling mediators acting downstream of Merlin/
NF2, we performed a mass spectrometry analysis of HEK293T
cells (human embryonic kidney cell line) engineered to overex-
press exogenous Merlin/NF2 tagged with flag epitope. In addi-
tion to previously known partners such as VprBP, DDB1, and
HECT E3 ubiquitin ligase, Lin28B was isolated as a new Merlin/
NF2-interacting protein (Table S1). This association between
Lin28B and Merlin/NF2 was confirmed by immunoprecipitation
analyses (Figure 1A) and demonstrated for the endogenous pro-
teins in H1299 cells (human lung cancer cell line) (Figure 1B). We
thenmade several deletion constructs of flag-taggedMerlin/NF2
to determine which region of Merlin/NF2 was responsible for
Lin28B binding. We found that this association requires parts
of Merlin/NF20s FERMdomain and the adjacent a-helical domain
(Figure 1C), both of which are implicated in Merlin/NF20s protein-
protein interactions and structural conformation changes.
Conversely, to identify the region of Lin28B that associates
with Merlin/NF2, we examined the binding of several truncated
constructs of myc-tagged Lin28B lacking its cold shock domain
(mycLin28BDC), the linker domain (mycLin28BDL), or the CCHC
zinc-finger domain (mycLin28BDZ) (Figure 1D). Flag-tagged
Merlin/NF2 failed to bind to mycLin28BDC (Figure 1D), the
construct lacking the cold shock domain essential for the phys-
ical interaction of Lin28B with the pre-let-7 family (Nam et al.,Reports 14, 2950–2961, March 29, 2016 ª2016 The Authors 2951
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Figure 2. Merlin/NF2 Promotes let-7 Maturation and Suppresses Lin28B Protein Levels
(A) IB to detect the indicated proteins in H1299 cells plated at high density (HD) and infected with lentivirus expressing the indicated shRNAs. Analysis was
performed at 3 days post-lentivirus infection. shCont, scrambled control shRNA.
(B) qPCR analysis of the indicated mature miRNAs in the H1299 cells in (A). Data were normalized to U6 snRNA and expressed relative to the level of control
shRNA (shCont) set to 1. Results are the mean ± SD (n = 3).
(C) IB to detect the indicated proteins in H290 cells that were plated at HD and infected with lentiviruses expressing empty mCherry vector (control), flagMerSA or
flagMerSD. Analysis was performed at 3 days post-lentivirus infection.
(D) qPCR analysis of the indicated mature miRNAs in the H290 cells in (C). Data were normalized as in (B) and expressed relative to the mCherry value set to 1.
Results are the mean ± SD (n = 3).
(E) IB to detect the indicated proteins in H1299 cells and infected with lentivirus expressing the indicated shRNAs. shY/T, shYAP/TAZ. Analysis was performed at
3 days post-lentivirus infection.
(F) qPCR analysis of the indicated mature miRNAs in the H1299 cells in (E). Data were normalized and analyzed as in (B). Results are the mean ± SD (n = 3).
*p < 0.05 (compared to shNF2 alone).
For all figures, *p < 0.05 by Student’s t test.2011; Piskounova et al., 2008). These findings raised the possi-
bility that Merlin/NF2 might regulate mlet-7 biogenesis via a
domain-specific interaction that inhibits Lin28B function.
Merlin/NF2 Regulates mlet-7 Biogenesis via Lin28B
To assess the involvement of Merlin/NF2 in regulating Lin28B
and let-7, we first examined the effect of Merlin/NF2 depletion
on protein levels of Lin28B and mlet-7 in H1299, Huh7 (hepato-
carcinoma cell line) and Caco2 (colon cancer cell line) cells, all
of which express Lin28B. Knockdown of Merlin/NF2 with short
hairpin RNAs (shRNAs) resulted in a slight increase in Lin28B
protein (Figures 2A, S1A, and S1C) and significant decreases
in mlet-7a, 7c, and 7g miRNAs, but it had no effect on the2952 Cell Reports 14, 2950–2961, March 29, 2016 ª2016 The AuthorLin28-independent miRNA miR-16 (Figures 2B, S1B, and S1D).
To confirm these effects of Merlin/NF2 on mlet-7 miRNAs and
Lin28B, we employed H290 cells, which are a malignant meso-
thelioma cell line with a homozygous deletion of the endogenous
Merlin/NF2 gene. Using lentivirus-mediated gene expression,
we engineered H290 cells to express one of two altered forms
of Merlin/NF2. Constitutive expression of a growth-inhibitory
(activated) form of Merlin/NF2 (termed flagMerSA), in which
there is an alanine substitution at the S518 phosphorylation
site, led to a striking increase in mlet-7 miRNAs and a decrease
in Lin28B. Conversely, expression of a phosphomimetic (in-
hibited) form of Merlin/NF2 (flagMerSD) had no effect on mlet-7
miRNAs and Lin28B (Figures 2C and 2D). These data supports
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Figure 3. Cell-Cell Contact Dephosphory-
lates Merlin/NF2 and Promotes Physical
Interaction between Merlin/NF2 and Lin28B
(A) IB to detect the indicated proteins in H1299
cells or H290 cells that were cultured at HD (H) or
low density (LD; L) for 3 days.
(B) qPCR analysis of the indicated mature miRNAs
in the cells in (A). Data were normalized as in
Figure 2B and are expressed relative to the LD
value set to 1. Results are the mean ± SD (n = 3).
*p < 0.05
(C) qPCR analysis of expression of pri-let7miRNAs
in H1299 cells and H290 cells that were cultured at
LD or HD. Data were normalized to actin mRNA
and are expressed relative to the LD value set to 1.
Results are the mean ± SD (n = 3).
(D) IB to detect the indicated proteins in H1299
cells that expressed the indicated flagMer con-
structs, were cultured at HD, and were immuno-
precipitated with anti-flag Ab.
(E) IB to detect the indicated proteins in H1299
cells that expressed the empty vector, flagMerWT
or flagMerSA, were cultured at LD or HD as in (A),
and were immunoprecipitated with anti-flag Ab.our hypothesis that Merlin/NF2 promotes the maturation of let-7
miRNAs while decreasing Lin28 protein.
Because the Hippo pathway effector YAP1 globally sup-
presses miRNA biogenesis in human keratinocyte HaCaT cells
(Mori et al., 2014), we investigated if YAP1/TAZ were involved
in Merlin/NF2-mediated regulation of mlet-7 miRNAs and
Lin28B in H1299 cells. The reduction in mlet-7 miRNAs and
elevation of Lin28B protein induced by Merlin/NF2 knockdown
were not significantly affected by shRNA-mediated suppression
of YAP1/TAZ, whereas changes to mlet-7 miRNA levels were
clearly reversed by Lin28B knockdown (Figures 2E and 2F).
These results show that the effects of Merlin/NF2 on mlet-7
biogenesis depend on Lin28B, but not on YAP1/TAZ.
Cell-Cell Contact Dephosphorylates Merlin/NF2 at S518
and Promotes Its Association with Lin28B
Since growth-inhibitory signaling triggered by cell-cell contact
is known to activate Merlin/NF2 through dephosphorylation at
S518 (Morrison et al., 2001), we examined whether cell-cell con-
tact affected levels of let-7 miRNAs and Lin28B in H1299 and
H290 cells. We observed that Merlin/NF2 S518 phosphorylation
was inhibited in H1299 cells plated at high cell density (Figure 3A)
and that H1299 cells (but not H290 cells) plated at high density
showed elevated mlet-7 miRNAs (Figure 3B) and decreased
Lin28B protein (Figures 3A and 3E). However, expression of
pri-let-7 miRNAs showed only subtle change in either H1299 orCell Reports 14, 2950–2961H290 cells under these culture conditions
(Figure 3C). This finding in H1299 cells
stands in contrast to a previous report
(Mori et al., 2014) and may be due to
differing sizes of the pri-let-7 pools in the
cell lines tested.
To investigate how Merlin/NF2 regu-
lates Lin28B during contact inhibition,we determined if cell-density-dependent dephosphorylation of
Merlin/NF2 at S518 altered its affinity for Lin28B. Immunoprecip-
itation analysis demonstrated that flagMerSA protein associated
with Lin28B more effectively than did either wild-type (WT)
Merlin/NF2 (flagMerWT) or flagMerSD (Figure 3D). Furthermore,
flagMerWT displayed a stronger affinity for Lin28B when it was
less highly phosphorylated at S518 (that is, at high cell density)
than when it was phosphorylated at S518 (at low cell density)
(Figure 3E). These findings suggest that cell-cell contact reduces
the phosphorylation of Merlin/NF2 in a way that strengthens its
association with Lin28B and inhibits Lin28B functions.
Cell-Cell Contact Regulates Subcellular Localization of
Lin28B via Merlin/NF2
The dynamic cell-density-dependent interaction we observed
between Merlin/NF2 and Lin28B prompted us to determine
whether Lin28B’s subcellular localization was altered in
response to cell-cell contact. To this end, we used immunofluo-
rescent staining to analyze the subcellular localization of endog-
enous Lin28B in H1299, Huh7, and Caco2 cells cultured at low or
high cell density. Consistent with previous reports (Piskounova
et al., 2011), in H1299 cells at low density, Lin28B was localized
in the nucleoli (identified by the nuclear/nucleolar marker B23) as
well as in the cytoplasm (Figures 4A and S2A). At high cell den-
sity, the nucleolar localization of Lin28B was abolished, but its
presence in the cytoplasm was maintained (Figure 4A). Similar, March 29, 2016 ª2016 The Authors 2953
A B C
D E F G
Figure 4. Cell-Cell Contact and Merlin/NF2 Controls the Nucleolar Localization of Lin28B
(A) Immunocytochemistry to detect endogenous Lin28B protein in the nucleoli of H1299 cells cultured at LD or HD. DAPI, nuclear stain. For all immunocyto-
chemistry analyses, results are representative of three independent experiments. Scale bar represents 20 mm.
(B) Immunocytochemistry to detect endogenous Lin28B protein in the nucleoli of H290 cells cultured at LD or HD for 3 days. Scale bar represents 20 mm.
(C) Immunocytochemistry to detect endogenous Merlin/NF2 protein in H1299 cells cultured at LD or HD as in Figure 3A. At LD, Merlin/NF2 appears in filopodia-
like structures and throughout the nucleus and cytoplasm. At HD, Merlin/NF2 localizes at the plasma membrane in the intercellular contact region. Scale bar
represents 20 mm.
(D) IB to detect the indicated proteins in the cytoplasmic (C), membrane (M), and nuclear (N) fractions of H1299 cells that were cultured at LD or HD. Lamin, nuclear
marker; a-tubulin, cytoplasmic marker; EGFR, plasma membrane marker.
(E) Immunocytochemistry to detect endogenous Lin28B protein in H1299 cells infected with lentivirus expressing shCont or shMerlin/NF2 (shNF2) and cultured at
HD for 3 days. Scale bar represents 20 mm.
(F) Immunocytochemistry to detect endogenous Lin28B protein in H290 cells that expressed Dox-inducible flagMerSA (H290MerSA) and were cultured at HD for
3 days. Cells were left untreated (Dox-) or were treated with Dox for 3 days prior to immunocytochemistry (Dox+). Scale bar represents 20 mm.
(G) Quantitation of BrdU incorporation in H290MerSA cells that were left untreated (Dox) or were treated with Dox for 3 days (Dox+) prior to 2 hr incubation with
BrdU. Cells were immunostained with anti-BrdU and anti-Lin28B Abs, and the number of BrdU+ cells was counted. Results are the mean ± SD (n = 3). *p < 0.05.
See also Figure S3B.results were obtained using Huh7 and Caco2 cells (Figures S2B
and S2C). In contrast, when we cultured Merlin/NF2-deficient
H290 cells at high density, Lin28B remained in the nucleoli (Fig-
ure 4B). These results imply that Merlin/NF2 is not required for
the entrance of Lin28B into the nucleolus but is necessary for
its exit from this organelle. When we examined the localization
of endogenous Merlin/NF2 in H1299 cells, we found that
Merlin/NF2 formed filopodia-like structures and was broadly
detectable in the cytoplasm of cells cultured at low density (Fig-
ure 4C, top). In contrast, in H1299 cells cultured at high density,
Merlin/NF2 appeared in the plasma membrane in the region of
intercellular contact (Figure 4C, bottom).
To confirm these changes to Merlin/NF2 localization during
contact inhibition, we prepared cytoplasmic (a-tubulin+), nuclear
(lamin+), and plasma membrane (EGFR+) fractions of H1299 cell2954 Cell Reports 14, 2950–2961, March 29, 2016 ª2016 The Authorlysates. At high cell density, both Lin28B and Merlin/NF2 were
decreased in the nuclear fraction but maintained at relatively
high levels in the cytoplasmic and plasma membrane fractions
(Figure 4D). In contrast, these proteins were detectable in all
fractions of H1299 cells at low cell density. Of note, Merlin/NF2
phosphorylated at S518 showedWT subcellular distribution (Fig-
ure 4D), implying that this phosphorylation site does not substan-
tially regulate Merlin/NF2’s subcellular localization. Consistent
with this hypothesis, both flagMerSA and flagMerSD behaved
similarly in fractionated lysates of H290 cells plated at low or
high density (Figure S3A).
We next examined the effects of Merlin/NF2 knockdown or
overexpression on subcellular Lin28B localization. The nucleolar
localization of Lin28B that disappeared in high density H1299
cells was recovered in Merlin/NF2-depleted H1299 cellss
A B Figure 5. Cell-Cell Contact Inhibits the Nu-
clear Function of Lin28B
(A) Immunocytochemistry to detect flagLin28BWT
or flagLin28BDC in HeLa cells that were infected
with lentivirus expressing the indicated proteins,
co-cultured at HD or LD for 3 days with uninfected
HeLa cells, and immunostained with anti-Lin28B
Ab. Scale bar represents 20 mm.
(B) Top: qPCR analysis of the indicated mature
miRNAs in the HeLa cells in (A). Data were
normalized to U6 snRNA and expressed relative to
the level of empty vector (mCh) set to 1. Results are
the mean ± SD (n = 3). *p < 0.05 (compared to WT
at LD). Bottom: IB to detect the indicated proteins
in the HeLa cells in the top panel.(Figure 4E). In addition, nucleolar localization of Lin28B was
attenuated in H290 cells expressing flagMerSA in a doxycycline
(Dox)-dependent manner (H290MerSA cells) (Figure 4F), leading
to a reduction in bromodeoxyuridine (BrdU)+ cells (Figures 4G
and S3B). Supporting this, subcellular fractionation also ex-
hibited that flagMerSA not only decreases the total level of
Lin28B proteins but also promotes translocation of Lin28B
out of nucleus, whereas flagMerSD did not alter subcellular pro-
portion of Lin28B localization compared to negative control
mCherry (Figure S3A). These data suggest that the regulation
of Merlin/NF2 mediated by cell-cell contact is actively involved
in translocating Lin28B out of the nucleolus.
Interaction between Merlin and Lin28B Promotes
Lin28B Translocation out of the Nucleus/Nucleolus,
Inhibits Lin28B/pri-let-7 Interaction, and Promotes
mlet-7 Biogenesis
We next compared responses to cell-cell contact between WT
Lin28B (flagLin28BWT) and flagLin28BDC (does not bind
Merlin/NF2; Figure 1D) in HeLa cells, which lack Lin28A/B
expression. Consistent with the subcellular localization of
endogenous Lin28B observed in H1299, Huh7, and Caco2 cells
(Figures 4A and S2A–S2C), the nucleolar localization of fla-
gLin28BWT in low-density HeLa cells disappeared at high den-
sity, whereas its cytoplasmic localization was still detectable
(Figure 5A). Moreover, the suppression of mlet-7miRNAs by fla-
gLin28BWT in low-density HeLa cells was impaired by cell-cell
contact, with no significant change in flagLin28BWT protein (Fig-
ure 5B). In contrast, flagLin28BDC was exclusively localized in
the nucleus/nucleoli regardless of cell density (Figure 5A), sug-
gesting that Merlin/NF2 cannot move flagLin28BDC out of the
nucleus even when activated. However, despite lacking the
cold shock domain, flagLin28BDC was still able to suppress
mlet7 miRNAs (Figure 5B), implying that the CCHC zinc finger
domain can facilitate pri-let-7 binding in the nucleus. Impor-
tantly, the activity of flagLin28BDC, unlike flagLin28BWT, was
not significantly affected by cell density (Figure 5B), probablyCell Reports 14, 2950–2961because flagLin28BDC was immune to
Merlin/NF2-mediated inhibition. Finally,
unlike in H1299 cells, flagMerSA did not
alter mlet7 expression in HeLa cells (Fig-
ures S4A and S4B). These data furtherindicate that Merlin/NF2 regulates let-7 biogenesis in a Lin28B-
dependentmanner. Thus,Merlin/NF2’s inhibition of Lin28B func-
tions is essential for the promotion of pri-let-7 processing that
occurs at high cell density.
We then investigated whether contact inhibition and/or the
presence of Merlin/NF2 altered the affinity of endogenous
Lin28B for the pri-let7miRNAs that predominates in the nucleus.
We devised an RNA immunoprecipitation (RIP) assay in which
amounts of endogenous Lin28B protein in cell extracts were
measured and equalized by immunoblotting, followed by immu-
noprecipitation of endogenous Lin28B protein with anti-Lin28B
antibody (Ab) and analysis of associated pri-let-7 miRNAs (Fig-
ures S5A–S5C). Application of this assay to H1299 cells plated
at high or low density showed that, consistent with our findings
on the subcellular localization of Lin28B, the binding of Lin28B
to pri-let-7 miRNAs was dramatically decreased in cells at high
density compared to those at low density (Figure 6A). In addition,
Merlin/NF2 depletion enhanced Lin28B binding to pri-let-7
miRNAs (Figure 6B), and flagMerSA more effectively blocked
the formation of the Lin28B/pri-let-7 miRNAs complex than did
flagMerWT (Figure 6C). These data collectively indicate that
activation of Merlin/NF2 by cell-cell contact causes it to alter
the subcellular localization of Lin28B and thereby regulate the
binding of Lin28B to the pri-let-7 family.
Growth-Inhibitory Activity of Merlin/NF2 Depends on Its
Effects on Lin28B and mlet7 Biogenesis
Given our finding that Merlin/NF2 promotes let-7 maturation
by sequestering Lin28B, we investigated whether Merlin/NF’s
involvement in mlet-7 biogenesis and Lin28B localization
contributed to Merlin/NF2-mediated tumor suppression. We first
examined the roles of Merlin/NF2 and Lin28B in the self-renewal
of tumor cells as assayed by sphere formation in H1299, Huh7,
and Caco2 cell cultures. Primary and/or secondary sphere for-
mation in such cultures was improved byMerlin/NF2 knockdown
but markedly inhibited by additional knockdown of Lin28B (Fig-
ures 7A and S6A–S6C) or YAP1/TAZ (Figure S6D). These data, March 29, 2016 ª2016 The Authors 2955
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Figure 6. Non-phosphorylated Merlin/NF2 Sequesters Lin28B and Prevents Its Interaction with Pri-let7
(A) Immunoprecipitation (RIP-IP, top) and qPCR (RIP-qPCR, bottom) for RIP assay examining the effect of contact inhibition on the physical interaction between
Lin28B and the indicated pri-let-7miRNAs in H1299 cells cultured at LD or HD. The amount of cell lysate used for each RIP assay was estimated according to the
Lin28B level in the corresponding IB shown in Figure S5A. Binding of pri-let-7miRNAs to Lin28B was normalized to pri-let-7 miRNA expression in the input cell
lysate. Data are the mean ± SD (n = 3).
(B) RIP-IP (top) and RIP-qPCR (bottom) assays examining the physical interaction between Lin28B and pri-let-7 miRNAs in H1299 cells infected with lentivirus
expressing the indicated shRNAs and cultured at HD. See also Figure S5B. Data are the mean ± SD (n = 3).
(C) RIP-IP (top) and RIP-qPCR (bottom) assays examining the physical interaction between Lin28B and pri-let-7 miRNAs in H1299 cells infected with lentivirus
expressing empty vector or the MerWT or MerSA constructs. See also Figure S5C. Data are the mean ± SD (n = 3).
For all figures, *p < 0.05.suggest that Merlin/NF2 normally suppresses the self-renewal of
tumor cells and that this self-renewal requires not only YAP1/
TAZ but also Lin28B.
Next, we evaluated if Lin28B overexpression via lentiviral
infection could prevent Merlin/NF2-mediated inhibition of the
proliferation of H290MerSA cells. Whereas Dox-induced flag-
MerSA expression alone significantly reduced H290MerSA pro-
liferation, co-expression of flagMerSA and Lin28B substantially
restored cell growth (Figure 7B). These results indicate that
Lin28B alone can partially compensate for loss of Merlin/NF2
function and that YAP1/TAZ may be required for complete
rescue of cell growth suppressed by Merlin/NF2. Because previ-
ous reports have indicated that Lin28 targets not only the let-7
miRNA family but also a variety of mRNAs known to regulate bio-
logical events such as neurogenesis and tissue repair (Rehfeld2956 Cell Reports 14, 2950–2961, March 29, 2016 ª2016 The Authoret al., 2015; Shyh-Chang et al., 2013), we also tested whether
knockdown of let-7miRNAswith locked nucleic acid (LNA) oligo-
nucleotides could alter Merlin/NF2-mediated growth suppres-
sion. LNAs directed against let-7 sequences efficiently blocked
endogenous expression of mlet-7 and stabilized several of its
known targets, including Lin28B, IMP1, and cMyc (Figures S7A
and S7B). Further supporting the biological significance of this
Merlin/NF2-Lin28B-let-7 axis, LNAs restored the growth of cells
expressing flagMerSA (Figure 7C). Because we confirmed that
let-7g overexpression inhibits cell growth as well as the expres-
sion of mlet-7 target proteins in H1299 and H290 cells (Figures
S7C and S7D), we examined the expression of these molecules
in our Merlin/NF2-mediated growth inhibition assay. Recovery of
Merlin/NF2 function in Dox-treated H290MerSA cells clearly
decreased Lin28B, IMP1, and cMyc protein levels (Figure 7D),s
A B C
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Figure 7. Merlin/NF2 Inhibits Cell Proliferation in a Lin28B/let-7-Dependent Manner
(A) (Left) Microscopic views of primary spheres formed in culture by H1299 cells that were infected with lentivirus expressing the indicated shRNAs for 2 days and
then dissociated into single cells. The number of spheres >200 mm diameter formed in culture was counted 8 days after dissociation. (Right) Quantitation of the
spheres formed in the left panel. Data are the mean ± SD (n = 3) per 1,000 cells. Scale bar represents 500 mm.
(B) Quantitation of numbers of viable H290MerSA cells that were infected with empty vector or lentivirus expressing Lin28B, cultured with/without Dox for the
indicated days, and stained with trypan blue on days 0, 2, 4 and 6. Data are the mean ± SD (n = 3).
(C) Quantitation of numbers of viable H290MerSA cells that were transfected with control scrambled oligos (sc) or let-7 LNAs, cultured with/without Dox for the
indicated days, and stained with trypan blue on days 0, 2, 4 and 6. Data are the mean ± SD (n = 3).
(D) IB to detect the indicated proteins in the H290MerSA cells in (B) on day 6.
(E) IB to detect the indicated proteins in the H290MerSA cells in (C) on day 6.
(F) Proposed model of how Merlin/NF2 might regulate Lin28B and mlet7 biogenesis during contact inhibition. Please see main text for description.
For all figures, *p < 0.05.and these reductions did not occur in cells expressing exoge-
nous Lin28B or let-7 LNAs (Figure 7E). These functional data
strongly suggest that Merlin/NF2 exerts its tumor-suppressive
activity by sequestering Lin28B and thus blocking its functions
in the nucleus/nucleoli. Such a decrease in Lin28B activity would
lead to an increase in mlet-7 and a subsequent reduction in let-7
target proteins that could otherwise promote tumor cell growth.
DISCUSSION
This study has identified Lin28B, a let-7 miRNA inhibitor, as a
target of Merlin/NF2 that is important for the latter’s tumor-sup-
pressive activity. Although the oncogenic and cell reprogram-Cellming properties of Lin28 proteins are well defined (Shyh-Chang
and Daley, 2013; Thornton and Gregory, 2012), exactly how
Lin28B is regulated in response to cellular signaling has been
difficult to determine. It is known that Musashi1 and SET7/9
enhance the localization of Lin28 in the nucleolus and inhibit
the nuclear cropping of let-7 family miRNAs during early neural
differentiation (Kawahara et al., 2011; Kim et al., 2014). Here,
we demonstrate that Lin28B is regulated by a signaling mecha-
nism that is activated by cell-cell contact. Specifically, we pro-
pose that Merlin/NF2 promotes let-7 miRNA maturation and
reduces cell growth by suppressing nuclear/nucleolar Lin28B
localization in a cell-contact-dependent manner (Figure 7F). In
the absence of cell-cell contact, phosphorylated Merlin/NF2Reports 14, 2950–2961, March 29, 2016 ª2016 The Authors 2957
(which has low affinity for Lin28B) is localized in the cytoplasm
and nucleus. Accordingly, Lin28B localizes freely in both the nu-
cleus/nucleolus and cytoplasm (Figures 4A, 4D, and S2A–S2C).
Nuclear/nucleolar Lin28B then decreases the maturation of pri-
let-7miRNAs, thereby allowing an accumulation of proteins pro-
moting cell growth. On the other hand, following cell-cell contact,
the non-phosphorylated form of Merlin/NF2 binds to Lin28B and
sequesters it in the cytoplasm and plasma membrane. Lin28B is
thus excluded from the nucleus/nucleolus, leading to an in-
crease in mlet-7 miRNAs, a reduction in growth-promoting pro-
teins, and a dampening of cell proliferation. Our report thus pro-
vides the first evidence of Merlin/NF2-dependent regulation of
Lin28B in response to contact inhibition and describes the ef-
fects of that regulation.
Although we observed that the subcellular localization of
Lin28B correlated with the phosphorylation status of Merlin/
NF2, the underlying mechanism by which cell contact-mediated
signaling controls Merlin/NF2 phosphorylation and localization
remains to be dissected. Consistent with previous reports (Mor-
rison et al., 2001; Okada et al., 2005), we observed that cell-con-
tact-mediated signaling triggered dephosphorylation of Merlin/
NF2 at S518, but whether it is indeed this form of Merlin/NF2
that inhibits cell growth is not yet established. Conflicting conclu-
sions regarding the phosphorylation-related localization of
Merlin/NF2 have been reported in previous studies. For example,
Li et al. described a form of Merlin/NF2 that was underphos-
phorylated at S518 and accumulated in the nucleus. This
Merlin/NF2 isoform was found to suppress tumorigenesis by
blocking the CRLDCAF1-mediated proteolysis pathway in human
cancer cell lines (Li et al., 2010). In contrast, several other groups
have reported that Merlin/NF2 phosphorylated at S518 is
enriched in either the nucleus or cytoplasm depending on the
cell type and cell-cycle stage (Guerrero et al., 2015; Muranen
et al., 2005). It remains possible that the nuclear localization
of Merlin/NF2 is regulated by a mechanism other than phos-
phorylation during contact inhibition, a subject currently under
investigation.
It has been previously reported that Lin28B is also a direct
downstream target of mlet-7 (Guo et al., 2006). In our study,
we observed that an increase or decrease in Lin28B consistently
correlated with knockdown or overexpression of let-7, respec-
tively (Figures S7A–S7D). Thus, alterations to Lin28B imposed
by loss or gain of Merlin/NF2 function may also depend on the
level of mlet-7. The usual pathways modulating protein stability
do not appear to be involved, since treatment of H1299 cells
with either MG132 (proteasome inhibitor) or bafilomycin (lyso-
some inhibitor) does not affect Lin28B protein levels (unpub-
lished data). Further studies are needed to evaluate whether
Merlin/NF2 deficiency is associated with mlet-7 reduction and/
or Lin28B accumulation in human tumors.
Recent work has shown that inactivation of the Hippo
pathway, or activation of its effectors YAP1/TAZ, inhibits the
miRNA microprocessor machinery and so causes widespread
miRNA suppression (Mori et al., 2014). Nevertheless, in our
study, knockdown of YAP1/TAZ failed to rescue the expression
of the mlet-7 family in Merlin/NF2-depleted H1299 cells (Figures
2E and 2F). Lin28 proteins have a direct effect on mlet-7 biogen-
esis, whereas YAP1 sequesters the microprocessor accessory2958 Cell Reports 14, 2950–2961, March 29, 2016 ª2016 The Authorprotein p72 and so may be a global suppressor of miRNAs.
One possible explanation for this discrepancy is that Lin28B
may have a stronger impact on mlet-7 biogenesis than does
YAP1 inMerlin/NF2-depleted cells. YAP1may be able to support
mlet-7 biogenesis in the absence of Lin28, since inhibition of
YAP1 enhances mlet7-dependent microprocessor reporter ac-
tivity in HaCaT cells (Mori et al., 2014). In fact, we could not
detect expression of Lin28 proteins in these cells in our prelimi-
nary immunoblot experiment (data not shown). However, we
cannot rule out another possibility: that the microprocessor ma-
chinery complex in H1299 cells does not utilize p72 but rather
p68, which is functionally related to p72 but free from YAP-medi-
ated sequestration.
In any case, our results indicate that Lin28B and YAP1/TAZ are
coordinately in charge of promoting the growth of Merlin/NF2-
deficient H1299 cells, because both proteins are necessary for
sphere formation following Merlin/NF2 depletion. Our data also
raise the possibility that malignant Merlin/NF2-related tumors
may exhibit both YAP1/TAZ activation and Lin28 accumulation,
a scenario supported by our observation that both occur in
H290 cells, a human Merlin/NF2-deficient malignant mesotheli-
oma cell line. Since Merlin/NF2-deficient mice are clearly predis-
posed to developing cancers in multiple tissues (McClatchey
et al., 1998), it will be interesting to analyze the contribution of
the Merlin/NF2-Lin28-let-7 axis, in addition to the canonical
Merlin/NF2-MST-LATS-YAP1 axis, to the prevention of tumor
development inmousemodels. The results of such studies could
point to a therapeutic approach that targets the Merlin/NF2-
Lin28-let-7 axis and might be beneficial for the treatment of
Merlin/NF2-related tumors in humans.
EXPERIMENTAL PROCEDURES
Cell Culture, Transfection, and Sphere Formation
HEK293T, Huh7, HeLa cells (JCRB), and Caco2 (ATCC) cells were maintained
in DMEM (GIBCO) supplemented with 10% fetal bovine serum (FBS; Hyclone)
and were transfected using linear polyethylenimine (MW 25,000; Polyscien-
ces). H1299 cells (ATCC) and H290 cells (a kind gift of Dr. A.F. Gazdar, Univer-
sity of Texas Southwestern Medical Center, Dallas, TX) were cultured in
RPMI1640 (Nacalai) supplemented with 10% FBS.
For analyses of cell-density-dependent responses, cells were cultured at
low (2 3 105/9.6cm2) or high (1.5 3 106/9.6cm2) cell density for 3 days. For
sphere formation, H1299 cells infected with lentivirus expressing specific
shRNAs were dissociated with trypsin-EDTA solution (Nacalai) and filtered
through a cell strainer (40-mm pores; BD Falcon). The resulting single-cell sus-
pensions were plated at 1,000 cells/ml in serum-free DMEM-F12 (Wako) con-
taining 10 ng/ml basic fibroblast growth factor (bFGF; R&D Systems), 20 ng/ml
EGF (Sigma), 5 ng/ml insulin (Nacalai), and 0.4% BSA (Sigma). Gene expres-
sion in the inducible H290 cell line was initiated by adding Dox (AppliChem)
to a final concentration of 100 ng/ml in the culture medium.
Plasmids
pCSC-flagMerlin/NF2, pCS2-mycLin28B, pCS2-flagLin28B, and pCS2-
flagMST1 were generated by PCR subcloning from cDNAs synthesized
using HEK293T total RNA. Point and deletion mutants of Merlin/NF2 and
Lin28B constructs were generated using single-primer-based site-directed
mutagenesis as described previously (Hikasa et al., 2010). A PCR fragment
of flagMerSAwas subcloned into aDox-inducible entry vector and then flipped
into the SLIK-neo vector using Gateway LRClonase II Enzymemix (Invitrogen).
Cloning and mutagenesis were verified by standard DNA sequencing.
Primer sequences for mutagenesis are listed in Supplemental Experimental
Procedures.s
Protein Identification by Mass Spectrometry
Lysates of HEK293T cells expressing flagMerWT were incubated with anti-
flag (M2)-conjugated agarose beads (Sigma) and fractionated by standard
SDS-PAGE. Gels were sliced into pieces, stained with silver (Sigma), and di-
gested with Trypsin Gold Mass Spectrometry grade (Promega). Digests
were analyzed with a nanoscale liquid chromatography-tandem mass spec-
trometry (LC-MS/MS) system employing an LTQ ion trap mass spectrometer
(Thermo Scientific). Initial identification of proteins from LC-MS/MS data was
performed using the Mascot search engine (Matrix Science). Any protein for
which peptides were also found in negative control lysates of HEK293T cells
was discarded.
Immunocytochemistry
H1299 and H290 cells were fixed with 4% paraformaldehyde for 5 min at room
temperature (RT), permeabilized with 0.1% Triton X-100 for 3 min at RT,
blocked with 3% FBS, and incubated at 4C overnight with Ab against
Lin28B (1:200, D4H1, #11965; Cell Signaling), Merlin/NF2 (1:200, #12896;
Cell Signaling) or B23 (1:500, B0556; Sigma). For double staining to detect
BrdU incorporation plus Lin28B protein, H290MerSA cells were treated with
1.5M HCl for 20 min prior to incubation with anti-Lin28B (1:200, D4H1,
#11965; Cell Signaling) and anti-BrdU (1:200, #5292; Cell Signaling) Abs. After
washing in PBS, cells were incubated for 3 hr with anti-rabbit Alexa 488
(1:1,000, A11008; Invitrogen) and/or anti-rabbit-Alexa Fluor 568 (1:1,000,
A11031; Invitrogen) Abs. Nuclei were visualized by DAPI staining (Wako).
Immunoprecipitation and Immunoblotting
Cells were lysed in lysis buffer containing 0.5%–1% Triton X-100, 50 mM Tris-
HCl, 50-150 mM NaCl, 1 mM EDTA, 0.1 mM PMSF, 10 mM NaF, and 1 mM
Na3VO4. Supernatants were incubated at 4
C overnight with anti-flag-agarose
beads (Sigma) or anti-Lin28B Ab (D4H1, #11965; Cell Signaling) plus Protein
G-agarose beads (Nacalai). Antibody-bound beads were washed three
times with lysis buffer, boiled in SDS-PAGE sample buffer, and subjected to
standard immunoblotting. Primary Abs recognized were Lin28B, Merlin/NF2,
Merlin/NF2 518S, pYAP1, YAP1, TAZ, a-tubulin, EGFR, IMP1 (all from Cell
Signaling: #11965, #12896, #13281, #4911, #4912, #4883, #2144, #4267,
and #8482, respectively); lamin (#16048; Abcam); 9E10 myc (sc-40; Santa
Cruz Biotechnology), or flag (M2) epitope (#S1804; Sigma). Primary Abs
were detected using horseradish peroxidase (HRP)-conjugated secondary
Abs (Cell Signaling).
Lentivirus-Mediated Gene Expression
Lentiviral vectors (CS-RfA-ETBsd, pENTRE4-H1) were obtained from the
RIKEN BRC DNA Bank and injected into HEK293T cells as described previ-
ously (Sasaki et al., 2011). Culture supernatants containing virus particles
were subjected to ultracentrifugation at 50,000 3 g for 2 hr to obtain concen-
trated lentivirus preparations. Sequences of shRNAs expressed by lentiviral
vectors are listed in Supplemental Experimental Procedures.
Oligonucleotide Transfection
Double-stranded oligoRNAs mimicking let-7g were obtained from Ambion
(mirVana miRNA mimic for let-7g), while locked nucleic acids (LNAs) against
let-7miRNAs were obtained from Exiqon (hsa-let-7miRCURY LNA microRNA
family inhibitor). Either scramble siRNA or double-stranded oligoDNA was
used as a negative control. Transfection of oligonucleotides (10 nM) into expo-
nentially growing H1299 or H290 cells was performed using Lipofectamine
RNAiMAX (Invitrogen) following the manufacturer’s protocol.
miRNA Expression Analysis
Total RNAs extracted with RNAiso (Takara) were subjected to reverse tran-
scription using the TaqMan MicroRNA RT Kit (Applied Biosystems). TaqMan
miRNA assays for U6 small nuclear RNA (snRNA), mlet-7a, 7c, 7g, and
miR16 (AppliedBiosystems)were used to quantifymaturemiRNAs. Expression
of pri-miRNAs was analyzed by qPCR using TaqMan Universal Master Mix II
(Applied Biosystems) with the TaqMan Pri-miRNA Assay for pri-let-7a, 7b,
and 7g (Applied Biosystems) and the TaqMan Gene Expression Assay for actin
(Applied Biosystems). All qPCR reactions were carried out using an ABI7500
real-time qPCR system. Data were normalized to U6 snRNA expression.CellSubcellular Fractionation
Nuclear, cytoplasmic, and plasma membrane fractions of cell lysates were
prepared using FOCUS SubCel (G-Biosciences) according to the manufac-
turer’s instructions. Subcellular fractionation was validated by immunoblotting
using anti-lamin (#16048; Abcam), anti-a-tubulin (#2144; Cell Signaling), and
anti-EGFR (#4267; Cell Signaling) Abs to identify nuclear, cytoplasmic, and
plasma membrane markers, respectively.
RNA Immunoprecipitation
RNA immunoprecipitation (RIP) assay was carried out using the EZ-Magna
RIP RNA-Binding Protein Immunoprecipitation Kit (Millipore) according to
the manufacturer’s instructions. H1299 cells expressing shRNA or flagMer
constructs were lysed and subjected to immunoblot analysis in order to
equalize amounts of endogenous Lin28B protein. Equalized cell lysates
were incubated for 4 hr at 4C with anti-Lin28B Ab (5 mg; Cell Signaling)
or control rabbit IgG (10 mg) conjugated to magnetic beads (50 ml). Mixtures
of beads, immunoprecipitated proteins, and miRNAs were magnetically
separated. Immunoprecipitated complexes were washed and treated with
proteinase K. RNA was extracted using the phenol/chloroform method and
converted to cDNA using the Transcriptor First Strand cDNA synthesis kit
(Roche). cDNA was then subjected to qRT-PCR to detect pri-let-7 family
member sequences.
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